Article Friendly article publishing script homepage.
Translate Page To German Tranlate Page To Spanish Translate Page To French Translate Page To Italian Translate Page To Japanese Translate Page To Korean Translate Page To Portuguese Translate Page To Chinese
  Number Times Read : 85    Word Count: 668  
Categories

Business
CGI
Coding Sites
Computers
Databases
Finances
Internet
Self Improvement
Technology
Web Design
Writing
 
Stats
Total Articles: 84
Total Authors: 7922
Total Downloads: 84832


Newest Member
Steven Ribbs

 


   

swine flu -a guide



[Valid RSS feed]  Category Rss Feed - http://bizarticlesonly.com/rss.php?rss=140
By : shabbir ahmed    29 or more times read
Submitted 2010-02-21 07:55:34
UNDERSTANDING INFLUENZA Influenza, or the common 'flu' is basically an illness that is caused by the RNA viruses, which infect the respiratory tract of animals, birds and human beings. An episode of influenza is usually marked by an amalgamation of symptoms, primarily including fever, cough, headache and excessive fatigue. In addition, in some cases, sore throat, nausea, vomiting and diarrhea might also occur. These symptoms usually last for up to two weeks or less and the patient recovers with no problems.

The swine influenza is basically an infection caused by one of the many types of the swine influenza viruses. As per the latest studies, the swine influenza virus strains include influenza C and the subtypes of influenza A, which are H1N1, H1N2, H3N1, H3N2 and H2N3. Basically, the swine flu is a respiratory disease of the pigs, caused by the influenza viruses and was originally isolated in 1930. In pigs, this particular disease is caused by the influenza type A and usually does not cause many deaths, though the disease causes illness in a large number of pigs, usually in the months of fall and winter in a year.

HISTORY OF VACCINES Research reveals an earlier instance of the development of the swine flu vaccine, in an attempt to control the spread of the disease. This particular vaccine was reportedly developed in order to tackle the 1976 flu outbreak, found in Fort Dix, New Jersey. Since the fear of another catastrophe like the 1918 Spanish Flu loomed large, a rampant vaccination program was started to immunize the masses against the flu. This fear emerged from the research reports that indicated that the swine flu strain found in this outbreak was similar to that of the 1918 Spanish Flu. Under the vaccination campaign, more than 40 million people in the United States were immunized between October 1976 to December 1976. However, later the immunization campaign was discontinued, as the swine flu pandemic actually didn't occur. In fact, the vaccination itself was being perceived to be causing a series of side effects, such as the Guillain-Barre Syndrome. 2009 INFLUENZA A (H1N1) MONOVALENT VACCINES The US Food and Drug Administration approved a series of four vaccines by changing a strain to each of the manufacturer's existing seasonal influenza vaccine. The strong experience these companies have in developing and manufacturing the seasonal influenza vaccine is reflected in the successful record of accomplishment of safety and effectiveness in the United States. These vaccinations are generally available in two different forms, including the a) Injectable vaccines and the b) Intranasal vaccine. The four vaccinations approved by the FDA include: * Influenza A (H1N1) 2009 Monovalent Vaccine - CSL Limited * Influenza A (H1N1) 2009 Monovalent Vaccine - ID Biochemical Corporation of Quebec * Influenza A (H1N1) 2009 Monovalent Vaccine - Novartis Vaccines and Diagnostics Limited * Influenza A (H1N1) 2009 Monovalent Vaccine - Sanofi Pasteur, Inc. * Meanwhile, the Intranasal Vaccine, which is the Influenza A (H1N1) 2009 Monovalent Vaccine is being manufactured by the MedImmune LLC.

In fact, the confirmation of the first batch of vaccine for the purpose of pre-clinical evaluation and testing came just a day after the World Health Organization declared the H1N1 virus as a pandemic on June 11, 2009. The batch was manufactured by the Swiss pharmaceuticals company, Novartis, at a plant in Marburg, Germany . According to Margaret A. Hamburg, M.D., Commissioner of Food and Drugs Administration, "The vaccine will help protect individuals from serious illness and death from influenza", stating that this approval is good news for the nation's response to the 2009 H1N1 influenza virus. According to a news release dated November 16, 2009, the US Food and Drug Administration announced its approval for an additional fifth vaccine to guard against the 2009 H1N1 influenza, manufactured by the ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC.
Author Resource:- Dr Shabbir Ahmed is a freelance writer with varied interests and based in the United Kingdom. http://www.swinefluguide.drshabbirahmed.com
Article From Biz Articles Only

HTML Ready Article. Click on the "Copy" button to copy into your clipboard.




Firefox users please select/copy/paste as usual
Rate This Article
Vote to see the results!

Do you like this article?
  • Yes.
  • Not Sure.
  • No.
New Members
select
Sign up
select
learn more
Affiliate Sign in
Affiliate Sign In
 
Nav Menu
Home
Login
Submit Articles
Submission Guidelines
Top Articles
Link Directory
About Us
Contact Us
Privacy Policy
RSS Feeds

Actions
Print This Article
Add To Favorites

 
Sponsors

Purchase this software